½ÃÀ庸°í¼­
»óǰÄÚµå
1766218

Ãʱ⠿µ¾ç ½ÃÀå ±âȸ, ¼ºÀå ÃËÁø¿äÀÎ, »ê¾÷ µ¿Ç⠺м® ¹× ¿¹Ãø(2025-2034³â)

Early Life Nutrition Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Global Market Insights Inc. | ÆäÀÌÁö Á¤º¸: ¿µ¹® 220 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°èÀÇ Ãʱ⠿µ¾ç ½ÃÀåÀº 2024³â 579¾ï ´Þ·¯·Î Æò°¡µÇ¾ú°í 2034³â¿¡´Â 1,275¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ÃßÁ¤µÇ¸ç, CAGR 8.2%·Î ¼ºÀåÇÒ Àü¸ÁÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ¼ºÀåÀº ¾ÆÀÌÀÇ »ýÈÄ Ã¹ 1,000ÀÏ µ¿¾ÈÀÇ ¿µ¾çÀÌ ½Åü ¹× Á¤½Å ¹ß´Þ, ¸é¿ª·Â, Àå±âÀûÀÎ °Ç°­¿¡ Å« ¿µÇâÀ» ¹ÌÄ£´Ù´Â ºÎ¸ðµéÀÇ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó ÃËÁøµÇ°í ÀÖ½À´Ï´Ù. ÀÇ·á Àü¹®°¡¿Í ºÎ¸ðµéÀº ¾ÆÀ̵éÀÇ ¼ºÀåÀ» Áö¿øÇϱâ À§ÇØ ¾Æ±â¿ë ½º³¼°ú ½Ã¸®¾ó, À¯¾Æ¿ë Á¶Á¦ ºÐÀ¯, ¿µ¾ç º¸ÃæÁ¦ µîÀÇ Á¦Ç°¿¡ Á¡Á¡ ´õ °ü½ÉÀ» µ¹¸®°í ÀÖ½À´Ï´Ù. °íǰÁúÀÇ ¿µ¾çÀÌ Ç³ºÎÇÑ Á¦Ç°¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖÀ¸¸ç, ºÎ¸ðµéÀº ÀÌ·¯ÇÑ ±âÁØÀ» ÃæÁ·ÇÏ´Â Á¦Ç°¿¡ ÇÁ¸®¹Ì¾öÀ» ±â²¨ÀÌ ÁöºÒÇÒ Àǻ簡 ÀÖ½À´Ï´Ù.

Ãʱ⠿µ¾ç ½ÃÀå-IMG1

µµ½ÃÈ­¿Í ÀÏÇÏ´Â ºÎ¸ðÀÇ ¼ö°¡ Áõ°¡ÇÔ¿¡ µû¶ó, ƯÈ÷ »ýȰ ¹æ½ÄÀÇ ¾ïÁ¦ ¿äÀÎÀ¸·Î ¸ðÀ¯ ¼öÀ¯°¡ ¾î·Á¿î µµ½Ã Áö¿ª¿¡¼­ Æí¸®ÇÏ°í ¿µ¾çÀÌ Ç³ºÎÇÑ 1ÀκР½Ä»ç ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ ±ÞÁõÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ½ÅÈï °æÁ¦±¹ÀÇ °¡Á¤Àº °¡Ã³ºÐ ¼ÒµæÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ÇÁ¸®¹Ì¾ö Ãʱ⠿µ¾ç Á¦Ç°À» ±¸¸ÅÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀåÀº Á¦Ç° ¶óÀξ÷À» È®ÀåÇϰí Áö¿ªº° ½Ä½À°ü¿¡ ¸ÂÃç Á¦Ç°À» Á¶Á¤ÇÏ¿© Áõ°¡ÇÏ´Â ¼ö¿ä¿¡ ´ëÀÀÇϰí ÀÖ½À´Ï´Ù.

½ÃÀå ¹üÀ§
½ÃÀÛ ¿¬µµ 2024³â
¿¹Ãø ¿¬µµ 2025-2034³â
½ÃÀÛ ±Ý¾× 579¾ï ´Þ·¯
¿¹Ãø ±Ý¾× 1,275¾ï ´Þ·¯
CAGR 8.2%

À¯¾Æ¿ë Á¶Á¦ ºÐÀ¯ ºÎ¹®Àº 2034³â±îÁö ½ÃÀå °¡Ä¡°¡ 620¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2025³âºÎÅÍ 2034³â±îÁö ¿¬Æò±Õ ¼ºÀå·üÀº 8.4%¸¦ ±â·ÏÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ÀÌ ºÎ¹®Àº ¸ðÀ¯ ¼öÀ¯¸¦ ¾î·Æ°Ô ÇÏ´Â ¾î¸Ó´ÏÀÇ Á÷Àå º¹±Í, µµ½ÃÈ­ ÁøÇà, »ýȰ ½À°üº´, ´Ù¾çÇÑ »çȸ ¹× °æÁ¦ º¯È­ µîÀÇ ¿äÀÎÀ¸·Î ÀÎÇØ ¼ºÀåÀ» º¸À̰í ÀÖ½À´Ï´Ù. À¯¾Æ¿ë Á¶Á¦ ºÐÀ¯´Â ¸¹Àº °¡Á·µé¿¡°Ô ¸ðÀ¯ ¼öÀ¯ÀÇ ÀûÀýÇÑ ´ë¾ÈÀÌ µÇ°í ÀÖ½À´Ï´Ù. Á¦Á¶»çµéÀº DHA, ARA, ´ºÅ¬·¹¿ÀƼµå µî ¼ººÐÀ» Ãß°¡ÇØ Àΰ£ ¸ðÀ¯¸¦ ¸ð¹æÇÑ Á¦Ç°ÀÇ ¼ººÐÀ» °³¼±Çϰí ÀÖ½À´Ï´Ù. À¯±â³ó ¹× Ư¼ö ºÐÀ¯¿¡ ´ëÇÑ ¼ö¿äµµ Áõ°¡Çϰí ÀÖÀ¸¸ç, ƯÈ÷ Àú¾Ë·¹¸£±â¼º, À¯´ç ¹«Ã·°¡, ½Ä¹°¼º ºÐÀ¯ µîÀÌ ´Ù¾çÇÑ ¼ÒºñÀÚ ¼±È£µµ¿¡ ¸ÂÃç Ãâ½ÃµÇ°í ÀÖ½À´Ï´Ù.

2024³â ±âÁØ ºÐ¸» ÇüŰ¡ 55%ÀÇ ÃÖ´ë ½ÃÀå Á¡À¯À²À» Â÷ÁöÇßÀ¸¸ç, 2025³âºÎÅÍ 2034³â±îÁö ¿¬Æò±Õ ¼ºÀå·ü(CAGR) 8.1%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ºÐ¸» Á¦Ç°Àº ºñ¿ë È¿À²¼º, È޴뼺, ±ä À¯Åë±âÇÑÀ¸·Î ÀÎÇØ ƯÈ÷ ³ÃÀå ½Ã¼³ÀÌ ºÎÁ·ÇÑ ½ÅÈï ½ÃÀå¿¡¼­ ÀûÇÕÇÕ´Ï´Ù. ¶ÇÇÑ ÀÌ ÇüÅ´ ´Ù¾çÇÑ ¹ß´Þ ´Ü°è¿¡ ¸Â´Â ƯÁ¤ ¿µ¾ç¼Ò¸¦ ÇÔÀ¯ÇÑ Á¦ÇüÀ» ½±°Ô ¸ÂÃãÈ­ÇÏ°í º¯°æÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀüÀÚ»ó°Å·¡ÀÇ ¿µÇâ·ÂÀÌ Ä¿Áü¿¡ µû¶ó ºÐ¸»Àº ¾×ü¿¡ ºñÇØ º¸°ü ¹× ¹è¼Û¿¡ ´õ ÀûÇÕÇϱ⠶§¹®¿¡ ÀÌ ºÎ¹®ÀÇ ¼ºÀåÀÌ ´õ¿í °­È­µÇ¾ú½À´Ï´Ù.

¾Æ½Ã¾ÆÅÂÆò¾ç Ãʱ⠿µ¾ç ½ÃÀåÀº 2024³â¿¡ 33.9%ÀÇ Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù. ÀÌ·¯ÇÑ ¿ìÀ§´Â ÀÌ Áö¿ªÀÇ ¸¹Àº Àα¸, °³¹ßµµ»ó±¹ÀÇ Ãâ»êÀ² Áõ°¡, Áß»êÃþ ¼ÒµæÀÇ Áõ°¡, À¯¾Æ °Ç°­ °ü¸®¿¡ ´ëÇÑ ÀνÄÀÇ Á¦°í, ½ÅÈï °æÁ¦±¹ÀÇ Á¸Àç¿Í °°Àº ¿äÀο¡ ±âÀÎÇÕ´Ï´Ù. Áß±¹, Àεµ, Àεµ³×½Ã¾Æ, º£Æ®³²°ú °°Àº ±¹°¡µéÀº ¼¼°è ¿µÀ¯¾Æ Àα¸ÀÇ »ó´ç ºÎºÐÀ» Â÷ÁöÇϱ⠶§¹®¿¡ ÀÌ Áö¿ªÀÇ °æÁ¦ ¹ßÀü¿¡ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾ç Áö¿ªÀÇ µµ½ÃÈ­ ¼öÁØÀº ¿©¼º¿¡°Ô ´õ ¸¹Àº Ãë¾÷ ±âȸ¸¦ Á¦°øÇϴ Ȱµ¿ÀûÀÎ »ýȰ ¹æ½Ä°ú °ü·ÃÀÌ ÀÖÀ¸¸ç, ÀÌ´Â ºÐÀ¯ ½Ä´Ü ¹× Æí¸®ÇÑ À°¾Æ ¼Ö·ç¼ÇÀ¸·ÎÀÇ ÀüȯÀ¸·Î À̾îÁö°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ º¯È­´Â ƯÈ÷ ºÐÀ¯ ¹× Áï½Ã ¼·Ãë °¡´ÉÇÑ Á¦Ç° ºÎ¹®ÀÇ Ãʱ⠿µ¾ç Á¦Ç°¿¡ ´ëÇÑ ¼ö¿ä¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÃÆ½À´Ï´Ù.

Ãʱ⠿µ¾ç ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷Àº Nestle SA, Danone SA, Abbott Laboratories, Reckitt Benckiser(Mead Johnson), FrieslandCampina µîÀÌ ÀÖ½À´Ï´Ù. ÀÌµé ±â¾÷Àº ´Ù¾çÇÑ Àü·«À» ÅëÇØ ½ÃÀå Á¡À¯À²À» °­È­Çϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î ³×½½·¹´Â ½Ã³ÊÁöƼ, ³­, ÀÏ·ç¹Ì³ª µî °í°¡ Á¦Ç°À» È«º¸Çϸç ÇÁ¸®¹Ì¾öÈ­ Àü·«À» ÃßÁøÇØ ¿µÀ¯¾Æ ¹× ¾î¸°ÀÌ ¿µ¾ç ½ÃÀå ¼ºÀå¿¡ ÁýÁßÇϰí ÀÖ½À´Ï´Ù. DanoneÀº Á¦Ç°¿¡ À¯±â³ó ¹× õ¿¬ ¿ø·á¸¦ °­Á¶Çϸç, À¯±â³ó ºÐÀ¯ Àü¹® ¼Ò±Ô¸ð ±â¾÷À» ÀμöÇØ ¼ÒºñÀÚ ¼±È£µµ¿¡ ¸ÂÃß°í ÀÖ½À´Ï´Ù.

¾Öº¸Æ®´Â ƯÁ¤ ºÐÀ¯ ¼±È£µµ¿¡ ¸Â´Â ´Ù¾çÇÑ Á¦Ç°À» Ãâ½ÃÇϱâ À§ÇØ Á¦Ç° ¶óÀξ÷À» È®ÀåÇϰí ÀÖÀ¸¸ç, ·¹Å¶º¥Å°Àú´Â ¿¬±¸ °³¹ß¿¡ ÅõÀÚÇØ Á¦Ç° Æ÷Æ®Æú¸®¿À¸¦ ´Ù°¢È­Çϰí ÀÖ½À´Ï´Ù. ÇÁ¸®½½·£µåÄ·Çdzª´Â Á¦Ç° ǰÁú °³¼±°ú À¯Åë ä³Î È®ÀåÀ» ÅëÇØ ´õ ³ÐÀº ¼ÒºñÀÚÃþÀ» È®º¸ÇÏ´Â µ¥ ÁýÁßÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Àü·«Àº ÀÌµé ±â¾÷ÀÌ º¯È­ÇÏ´Â ¼ÒºñÀÚ ¼ö¿ä¿¡ ÀûÀÀÇÏ°í °æÀïÀÌ Ä¡¿­ÇÑ Ãʱ⠿µÀ¯¾Æ ¿µ¾ç ½ÃÀå¿¡¼­ ÀÔÁö¸¦ °­È­ÇÏ´Â µ¥ ±â¿©Çϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå »ê¾÷ °íÂû

  • »ýÅÂ°è ºÐ¼®
    • °ø±ÞÀÚÀÇ »óȲ
    • ÀÌÀÍ·ü
    • °¢ ´Ü°è¿¡¼­ÀÇ ºÎ°¡°¡Ä¡
    • ¹ë·ùüÀο¡ ¿µÇâÀ» ÁÖ´Â ¿äÀÎ
    • Çõ½Å
  • »ê¾÷¿¡ ¹ÌÄ¡´Â ¿µÇâ¿äÀÎ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • °³¹ßµµ»ó±¹ÀÇ Ãâ»ý·ü Áõ°¡
      • ¿©¼º °í¿ë·ü Áõ°¡
      • Ãʱ⠿µ¾ç ¼·Ãë°¡ Àå±â °Ç°­¿¡ ¹ÌÄ¡´Â ¿µÇâ¿¡ ´ëÇÑ ÀÎ½Ä Çâ»ó
      • ¿µ¾çÇÐ ¹× ¿ø·á ±â¼úÀÇ ¹ßÀü
    • »ê¾÷ÀÇ ÀáÀçÀû ¸®½ºÅ© ¹× °úÁ¦
      • ¼±Áø±¹¿¡¼­ÀÇ Ãâ»ý·ü °¨¼Ò
      • º¸°Ç ±â°üÀÇ ¸ðÀ¯ ¼öÀ¯ Àå·Á Á¤Ã¥
      • ¾ö°ÝÇÑ ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©
      • ½ÅÈï ½ÃÀå¿¡¼­ÀÇ ³ôÀº °¡°Ý ¹Î°¨µµ
    • ½ÃÀå ±âȸ
      • ÇÁ¸®¹Ì¾ö Á¦Ç°°ú Àü¹® Á¦Ç° °³¹ß
      • ½ÅÈï ½ÃÀåÀ¸·Î È®´ë
      • À¯±â³ó ¹× Ŭ¸° ¶óº§ Á¦Çü
      • ÀüÀÚ»ó°Å·¡ ¹× ¼ÒºñÀÚ Á÷Á¢ ÆÇ¸Å ä³Î
    • ¼ºÀå °¡´É¼º ºÐ¼®
    • ±ÔÁ¦ »óȲ
      • WHO ¸ðÀ¯ ´ëüǰÀÇ ¸¶ÄÉÆÃ¿¡ °üÇÑ ±¹Á¦±Ô¾à
      • FDA ±ÔÁ¦
      • À¯·´ ½Äǰ¾ÈÀü±â±¸(EFSA) °¡À̵å¶óÀÎ
      • ÄÚµ¦½º ±Ô°Ý
      • ±¹°¡º° ±ÔÁ¤
      • ¶óº§ ¿ä°Ç°ú °Ç°­ °­Á¶ Ç¥½Ã
    • Porter's Five Forces ºÐ¼®
    • PESTEL ºÐ¼®
    • ÇöÀçÀÇ ±â¼ú µ¿Çâ
    • ½ÅÈï±â¼ú
  • °¡°Ý µ¿Çâ
    • Áö¿ªº°
    • Á¦Ç°º°
  • Àå·¡ ½ÃÀå µ¿Çâ
  • ±â¼ú°ú Çõ½ÅÀÇ »óȲ
    • ÇöÀçÀÇ ±â¼ú µ¿Çâ
    • ½ÅÈï±â¼ú
  • ƯÇã »óȲ
  • ¹«¿ª Åë°è(HSÄÚµå)(Âü°í : ¹«¿ª Åë°è´Â ÁÖ¿ä ±¹°¡¿¡¼­¸¸ Á¦°øµÊ)
    • ÁÖ¿ä ¼öÀÔ±¹
    • ÁÖ¿ä ¼öÃâ±¹
  • Áö¼Ó°¡´É¼º°ú ȯ°æ Ãø¸é
    • Áö¼Ó °¡´ÉÇÑ »ç·Ê
    • Æó±â¹° »è°¨ Àü·«
    • »ý»ê¿¡ À־ÀÇ ¿¡³ÊÁö È¿À²
    • ģȯ°æ Ȱµ¿

Á¦4Àå °æÀï ±¸µµ

  • ¼Ò°³
  • ±â¾÷ÀÇ ½ÃÀå Á¡À¯À² ºÐ¼®
    • Áö¿ªº°
      • ºÏ¹Ì
      • À¯·´
      • ¾Æ½Ã¾ÆÅÂÆò¾ç
      • ¶óƾ¾Æ¸Þ¸®Ä« Ç×°ø
      • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
  • ±â¾÷ ¸ÅÆ®¸¯½º ºÐ¼®
  • ÁÖ¿ä ½ÃÀå ±â¾÷ÀÇ °æÀï ºÐ¼®
  • °æÀï Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º
    • ÇÕº´°ú Àμö
    • ÆÄÆ®³Ê½Ê ¹× Çù¾÷
    • ½ÅÁ¦Ç° ¹ß¸Å
  • È®´ë °èȹ

Á¦5Àå ½ÃÀå ÃßÁ¤ ¹× ¿¹Ãø : Á¦Ç° À¯Çüº°(2021-2034³â)

  • ÁÖ¿ä µ¿Çâ
  • À¯¾Æ¿ë Á¶Á¦ ºÐÀ¯
    • Ç¥ÁØ À¯¾Æ¿ë Á¶Á¦ ºÐÀ¯
    • Ư¼ö À¯¾Æ¿ë Á¶Á¦ ºÐÀ¯
    • ÈÄ¼Ó Á¶Á¦ ºÐÀ¯
    • ¼ºÀå±â¿ë ¿ìÀ¯
  • ÀÌÀ¯½Ä
    • Á¶¸®µÈ À¯¾Æ½Ä
    • °ÇÁ¶ À¯¾Æ½Ä
    • ¾Æ±â ½Ã¸®¾ó
    • ¾Æ±â ½º³¼
    • ±âŸ
  • º¸Á¶ ½Äǰ
  • ¿µ¾çº¸Á¶½Äǰ
    • ºñŸ¹Î°ú ¹Ì³×¶ö
    • ÇÁ·Î¹ÙÀÌ¿Àƽ½º¿Í ÇÁ¸®¹ÙÀÌ¿Àƽ½º
    • DHA¿Í ARA º¸ÃæÁ¦
    • ±âŸ

Á¦6Àå ½ÃÀå ÃßÁ¤ ¹× ¿¹Ãø : Çüź°(2021-2034³â)

  • ÁÖ¿ä µ¿Çâ
  • ºÐ¸»
    • ¾×ü
    • Áï½Ã ¼·Ãë °¡´É Á¦Ç°
    • ³óÃà¾×
  • ¹Ý°íü
  • ±âŸ

Á¦7Àå ½ÃÀå ÃßÁ¤ ¹× ¿¹Ãø : Àü¹® ºÎ¹®º°(2021-2034³â)

  • ÁÖ¿ä µ¿Çâ
  • Ç¥ÁØÁ¦Ç°
  • Àú ¾Ë·¹¸£±â¼º Á¦Ç°
  • À¯´ç ¹«ÇÔÀ¯ Á¦Ç°
  • À¯±â³ó Á¦Ç°
  • ºñÀ¯ÀüÀÚ ÀçÁ¶ÇÕ Á¦Ç°
  • ¹Ì¼÷¾Æ¿ë Á¦Ç°
  • ±âŸ

Á¦8Àå ½ÃÀå ÃßÁ¤ ¹× ¿¹Ãø : ½ÄÀ纰(2021-2034³â)

  • ÁÖ¿ä µ¿Çâ
  • ź¼öÈ­¹°
    • À¯´ç
    • ¸»Å䵦½ºÆ®¸°
    • ¼öÅ©·Î½º
    • ±âŸ
  • ´Ü¹éÁú
    • ¿ìÀ¯ ´Ü¹éÁú
    • Äá ´Ü¹éÁú
    • ´Ü¹éÁú °¡¼öºÐÇØ¹°
    • ±âŸ
  • Áö¹æ
    • ½Ä¹°¼º ±â¸§
    • Áß¼â Áö¹æ»ê Æ®¸®±Û¸®¼¼¸®µå
    • ±âŸ
  • ºñŸ¹Î°ú ¹Ì³×¶ö
  • ÇÁ¸®¹ÙÀÌ¿Àƽ½º
    • °¥¶ôÅä ¿Ã¸®°í´ç(GOS)
    • ÇÁ·èÅä¿Ã¸®°í´ç(FOS)
    • ±âŸ
  • ÇÁ·Î¹ÙÀÌ¿Àƽ½º
  • ´ºÅ¬·¹¿ÀƼµå
  • ¸ðÀ¯ ¿Ã¸®°í´ç(HMO)
  • ±âŸ

Á¦9Àå ½ÃÀå ÃßÁ¤ ¹× ¿¹Ãø : ¿¬·ÉÃþº°(2021-2034³â)

  • ÁÖ¿ä µ¿Çâ
  • 0-6°³¿ù
  • 6-12°³¿ù
  • 12-24°³¿ù
  • 24-36°³¿ù
  • 36°³¿ù ÀÌ»ó

Á¦10Àå ½ÃÀå ÃßÁ¤ ¹× ¿¹Ãø : À¯Åë ä³Îº°(2021-2034³â)

  • ÁÖ¿ä µ¿Çâ
  • ½´ÆÛ¸¶ÄÏ ¹× ´ëÇü ½´ÆÛ¸¶ÄÏ
  • Àü¹®Á¡
  • ¾à±¹°ú ¾à±¹
  • ÆíÀÇÁ¡
  • ¿Â¶óÀÎ ¼Ò¸Å
    • ÀüÀÚ»ó°Å·¡ Ç÷§Æû
    • ¼ÒºñÀÚ Á÷Á¢ ÆÇ¸Å À¥»çÀÌÆ®
    • ±¸µ¶ ¼­ºñ½º
  • ±âŸ

Á¦11Àå ½ÃÀå ÃßÁ¤ ¹× ¿¹Ãø : Áö¿ªº°(2021-2034³â)

  • ÁÖ¿ä µ¿Çâ
  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
  • À¯·´
    • µ¶ÀÏ
    • ¿µ±¹
    • ÇÁ¶û½º
    • ½ºÆäÀÎ
    • ÀÌÅ»¸®¾Æ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • È£ÁÖ
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ¾Æ¸£ÇîÆ¼³ª
    • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ³²¾ÆÇÁ¸®Ä«
    • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦12Àå ±â¾÷ ÇÁ·ÎÆÄÀÏ

  • Nestle SA
  • Danone SA
  • Abbott Laboratories
  • Reckitt Benckiser Group plc(Mead Johnson & Company, LLC)
  • FrieslandCampina
  • Hain Celestial Group
  • Perrigo Company plc
  • Bellamy's Organic
  • Hero Group
  • Bubs Australia Limited
  • China Feihe Limited
  • Ausnutria Dairy Corporation Ltd.
  • HiPP GmbH & Co. Vertrieb KG
  • Gerber Products Company(Nestle)
  • Plum Organics(Campbell Soup Company)
HBR 25.07.16

The Global Early Life Nutrition Market was valued at USD 57.9 billion in 2024 and is estimated to grow at a CAGR of 8.2% to reach USD 127.5 billion by 2034. This growth is driven by increasing awareness among parents about the importance of nutrition during the first 1,000 days of a child's life, which significantly impacts physical and mental development, immunity, and long-term health. Healthcare practitioners and parents are increasingly turning to products like baby snacks and cereals, infant formula, and nutritional supplements to support their children's growth. The demand for high-quality, nutrient-enriched products is rising, with parents willing to pay a premium for items that meet these standards.

Early Life Nutrition Market - IMG1

Urbanization and the growing number of working parents have led to a surge in the need for convenient, single-serve, and nutritious meal solutions, especially in urban areas where lifestyle constraints make breastfeeding challenging. Additionally, families in emerging economies are experiencing increased disposable income, enabling them to purchase premium early-life nutrition products. These markets are expanding their product ranges and adapting to local dietary needs to cater to this growing demand.

Market Scope
Start Year2024
Forecast Year2025-2034
Start Value$57.9 Billion
Forecast Value$127.5 Billion
CAGR8.2%

The infant formula segment is expected to reach a market value of USD 62 billion by 2034, registering a CAGR of 8.4% during 2025-2034. This category is experiencing growth due to factors such as mothers returning to work, greater urbanization, lifestyle diseases that make breastfeeding difficult, and various social and economic changes. Infant formula offers an adequate alternative to breastfeeding for many families. Manufacturers are enhancing the composition of these products by adding ingredients like DHA, ARA, and nucleotides to simulate human milk. There's also an increased demand for organic and specialty formulas, including those that are hypoallergenic, lactose-free, and plant-based, to cater to diverse consumer preferences.

In 2024, the powdered form held the largest market share, accounting for 55%, and is projected to grow at a CAGR of 8.1% from 2025 to 2034. Powdered products are popular due to their cost-effectiveness, portability, and long shelf life, making them especially suitable for emerging economies with limited refrigeration. This form also allows for easy customization and alteration of formulations with specific nutrients for different developmental stages. The growing influence of e-commerce has further strengthened this segment, as powders are more suitable for storage and shipping compared to liquids.

Asia Pacific Early Life Nutrition Market held a 33.9% share in 2024. This dominance is attributed to factors such as the region's large population, increasing birth rates in developing countries, rising middle-class income, growing awareness of infant healthcare, and the presence of emerging economies. Countries like China, India, Indonesia, and Vietnam are vital to the region's evolving economy, as they constitute a significant portion of the world's infant and toddler demographic. The level of urbanization in Asia Pacific is associated with active lifestyles that afford women more employment opportunities, leading to a shift towards formula diets and convenient nurturing solutions. This shift has positively impacted the demand for early-life nutrition products, particularly among the powdered and ready-to-feed categories.

The leading companies in the Early Life Nutrition Market include Nestle S.A., Danone S.A., Abbott Laboratories, Reckitt Benckiser (Mead Johnson), and FrieslandCampina. These companies are strengthening their market presence through various strategies. Nestle, for instance, is focusing on premiumization by promoting higher-priced products like Sinergity, NAN, and Illumina, targeting growth in infant and children's nutrition. Danone is emphasizing organic and natural ingredients in its products, acquiring smaller businesses specializing in organic formulas to align with consumer preferences.

Abbott is expanding its product line to offer a variety of options catering to specific formula preferences, while Reckitt Benckiser is investing in research and development to diversify its product portfolio. FrieslandCampina is focusing on enhancing product quality and expanding its distribution channels to reach a broader consumer base. These strategies are helping these companies to adapt to changing consumer demands and strengthen their positions in the competitive early-life nutrition market.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope and definition
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Data mining sources
    • 1.3.1 Global
    • 1.3.2 Regional/Country
  • 1.4 Base estimates and calculations
    • 1.4.1 Base year calculation
    • 1.4.2 Key trends for market estimation
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
  • 1.6 Forecast model
  • 1.7 Research assumptions and limitations

Chapter 2 Executive Summary

  • 2.1 Industry 3600 synopsis
  • 2.2 Key market trends
    • 2.2.1 Product type
    • 2.2.2 Form trends
    • 2.2.3 Specialty type trends
    • 2.2.4 Ingredients type trends
    • 2.2.5 Age group
    • 2.2.6 Packaging type
    • 2.2.7 Distribution Channel
  • 2.3 TAM Analysis, 2025-2034
  • 2.4 CXO perspectives: Strategic imperatives
    • 2.4.1 Executive decision points
    • 2.4.2 Critical success factors
  • 2.5 Future Outlook and strategic recommendations

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
    • 3.1.1 Supplier landscape
    • 3.1.2 Profit margin
    • 3.1.3 Value addition at each stage
    • 3.1.4 Factor affecting the value chain
    • 3.1.5 Disruptions
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Rising birth rates in developing economies
      • 3.2.1.2 Increasing maternal employment rates
      • 3.2.1.3 Growing awareness of early nutrition impact on long-term health
      • 3.2.1.4 Advancements in nutritional science and ingredient technology
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 Declining birth rates in developed countries
      • 3.2.2.2 Promotion of breastfeeding by health organizations
      • 3.2.2.3 Stringent regulatory framework
      • 3.2.2.4 High price sensitivity in emerging markets
    • 3.2.3 Market opportunities
      • 3.2.3.1 Development of premium and specialized products
      • 3.2.3.2 Expansion in emerging markets
      • 3.2.3.3 Organic and clean label formulations
      • 3.2.3.4 E-commerce and direct-to-consumer channels
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
    • 3.4.1 WHO International Code of Marketing of Breast-milk Substitutes
    • 3.4.2 FDA regulations
    • 3.4.3 European Food Safety Authority (EFSA) Guidelines
    • 3.4.4 Codex Alimentarius Standards
    • 3.4.5 Country-specific regulations
    • 3.4.6 Labeling requirements and health claims
  • 3.5 Porter's analysis
  • 3.6 PESTEL analysis
    • 3.6.1 Technology and Innovation landscape
      • 3.6.1.1 Processing technologies
      • 3.6.1.2 Packaging innovations
      • 3.6.1.3 Ingredient technologies
      • 3.6.1.4 Digital marketing and e-commerce integration
    • 3.6.2 Current technological trends
    • 3.6.3 Emerging technologies
  • 3.7 Price trends
    • 3.7.1 By region
    • 3.7.2 By product
  • 3.8 Future market trends
  • 3.9 Technology and Innovation landscape
    • 3.9.1 Current technological trends
    • 3.9.2 Emerging technologies
  • 3.10 Patent Landscape
  • 3.11 Trade statistics (HS code) (Note: the trade statistics will be provided for key countries only)
    • 3.11.1 Major importing countries
    • 3.11.2 Major exporting countries
  • 3.12 Sustainability and environmental aspects
    • 3.12.1 Sustainable practices
    • 3.12.2 Waste reduction strategies
    • 3.12.3 Energy efficiency in production
    • 3.12.4 Eco-friendly Initiatives

Chapter 4 Competitive Landscape, 2024

  • 4.1 Introduction
  • 4.2 Company market share analysis
    • 4.2.1 By region
      • 4.2.1.1 North America
      • 4.2.1.2 Europe
      • 4.2.1.3 Asia Pacific
      • 4.2.1.4 LATAM
      • 4.2.1.5 MEA
  • 4.3 Company matrix analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Key developments
    • 4.6.1 Mergers & acquisitions
    • 4.6.2 Partnerships & collaborations
    • 4.6.3 New Product Launches
  • 4.7 Expansion Plans

Chapter 5 Market Estimates & Forecast, By Product Type, 2021-2034 (USD Billion) (Kilo Tons)

  • 5.1 Key trends
  • 5.2 Infant formula
    • 5.2.1 Standard infant formula
    • 5.2.2 Specialty infant formula
    • 5.2.3 Follow-on formula
    • 5.2.4 Growing-up milk
  • 5.3 Baby food
    • 5.3.1 Prepared baby food
    • 5.3.2 Dried baby food
    • 5.3.3 Baby cereals
    • 5.3.4 Baby snacks
    • 5.3.5 Others
  • 5.4 Complementary foods
  • 5.5 Nutritional supplements
    • 5.5.1 Vitamins and minerals
    • 5.5.2 Probiotics and prebiotics
    • 5.5.3 DHA and ARA supplements
    • 5.5.4 Others

Chapter 6 Market Estimates & Forecast, By Form, 2021-2034 (USD Billion) (Kilo Tons)

  • 6.1 Key trends
  • 6.2 Powder
    • 6.2.1 Liquid
    • 6.2.2 Ready-to-feed
    • 6.2.3 Concentrated liquid
  • 6.3 Semi-solid
  • 6.4 Others

Chapter 7 Market Estimates & Forecast, By Specialty Type, 2021-2034 (USD Billion) (Kilo Tons)

  • 7.1 Key trends
  • 7.2 Standard products
  • 7.3 Hypoallergenic products
  • 7.4 Lactose-free products
  • 7.5 Organic products
  • 7.6 Non-GMO products
  • 7.7 Products for premature infants
  • 7.8 Others

Chapter 8 Market Estimates & Forecast, By Ingredient Types, 2021-2034 (USD Billion) (Kilo Tons)

  • 8.1 Key trends
  • 8.2 Carbohydrates
    • 8.2.1 Lactose
    • 8.2.2 Maltodextrin
    • 8.2.3 Sucrose
    • 8.2.4 Others
  • 8.3 Proteins
    • 8.3.1 Cow's milk protein
    • 8.3.2 Soy protein
    • 8.3.3 Protein hydrolysates
    • 8.3.4 Others
  • 8.4 Fats
    • 8.4.1 Vegetable oils
    • 8.4.2 Medium-chain triglycerides
    • 8.4.3 Others
  • 8.5 Vitamins and minerals
  • 8.6 Prebiotics
    • 8.6.1 Galacto-oligosaccharides (GOS)
    • 8.6.2 Fructo-oligosaccharides (FOS)
    • 8.6.3 Others
  • 8.7 Probiotics
  • 8.8 Nucleotides
  • 8.9 Human milk oligosaccharides (HMOs)
  • 8.10 Others

Chapter 9 Market Estimates & Forecast, By Age Group, 2021-2034 (USD Billion) (Kilo Tons)

  • 9.1 Key trends
  • 9.2 0–6 months
  • 9.3 6–12 months
  • 9.4 12–24 months
  • 9.5 24–36 months
  • 9.6 Above 36 months

Chapter 10 Market Estimates & Forecast, By Distribution Channel, 2021-2034 (USD Billion) (Kilo Tons)

  • 10.1 Key trends
  • 10.2 Supermarkets and hypermarkets
  • 10.3 Specialty stores
  • 10.4 Pharmacies and drug stores
  • 10.5 Convenience stores
  • 10.6 Online retail
    • 10.6.1 E-commerce platforms
    • 10.6.2 Direct-to-consumer websites
    • 10.6.3 Subscription services
  • 10.7 Others

Chapter 11 Market Estimates & Forecast, By Region, 2021-2034 (USD Billion) (Kilo Tons)

  • 11.1 Key trends
  • 11.2 North America
    • 11.2.1 U.S.
    • 11.2.2 Canada
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 UK
    • 11.3.3 France
    • 11.3.4 Spain
    • 11.3.5 Italy
    • 11.3.6 Rest of Europe
  • 11.4 Asia Pacific
    • 11.4.1 China
    • 11.4.2 India
    • 11.4.3 Japan
    • 11.4.4 Australia
    • 11.4.5 South Korea
    • 11.4.6 Rest of Asia Pacific
  • 11.5 Latin America
    • 11.5.1 Brazil
    • 11.5.2 Mexico
    • 11.5.3 Argentina
    • 11.5.4 Rest of Latin America
  • 11.6 MEA
    • 11.6.1 Saudi Arabia
    • 11.6.2 South Africa
    • 11.6.3 UAE
    • 11.6.4 Rest of Middle East and Africa

Chapter 12 Company Profiles

  • 12.1 Nestle S.A.
  • 12.2 Danone S.A.
  • 12.3 Abbott Laboratories
  • 12.4 Reckitt Benckiser Group plc (Mead Johnson & Company, LLC)
  • 12.5 FrieslandCampina
  • 12.6 Hain Celestial Group
  • 12.7 Perrigo Company plc
  • 12.8 Bellamy's Organic
  • 12.9 Hero Group
  • 12.10 Bubs Australia Limited
  • 12.11 China Feihe Limited
  • 12.12 Ausnutria Dairy Corporation Ltd.
  • 12.13 HiPP GmbH & Co. Vertrieb KG
  • 12.14 Gerber Products Company (Nestle)
  • 12.15 Plum Organics (Campbell Soup Company)
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦